Hemenway Trust Hemenway Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $309K | Hold |
11,000
| – | – | 0.02% | 103 |
|
|
2025
Q4 | $274K | Hold |
11,000
| – | – | 0.02% | 105 |
|
|
2025
Q3 | $280K | Sell |
11,000
-1,000
| -8% | -$24.7K | 0.02% | 102 |
|
|
2025
Q2 | $291K | Hold |
12,000
| – | – | 0.02% | 97 |
|
|
2025
Q1 | $304K | Sell |
12,000
-250
| -2% | -$6.54K | 0.02% | 98 |
|
|
2024
Q4 | $325K | Sell |
12,250
-969
| -7% | -$26.3K | 0.03% | 95 |
|
|
2024
Q3 | $383K | Sell |
13,219
-2,631
| -17% | -$76.8K | 0.03% | 97 |
|
|
2024
Q2 | $443K | Sell |
15,850
-4,875
| -24% | -$134K | 0.04% | 91 |
|
|
2024
Q1 | $575K | Sell |
20,725
-1,275
| -6% | -$35.4K | 0.05% | 81 |
|
|
2023
Q4 | $633K | Buy |
22,000
+125
| +0.6% | +$3.78K | 0.06% | 76 |
|
|
2023
Q3 | $726K | Sell |
21,875
-1,375
| -6% | -$48.6K | 0.08% | 74 |
|
|
2023
Q2 | $853K | Hold |
23,250
| – | – | 0.08% | 70 |
|
|
2023
Q1 | $949K | Sell |
23,250
-3,750
| -14% | -$162K | 0.1% | 70 |
|
|
2022
Q4 | $1.38M | Sell |
27,000
-750
| -3% | -$36K | 0.15% | 62 |
|
|
2022
Q3 | $1.21M | Buy |
27,750
+2,668
| +11% | +$130K | 0.14% | 63 |
|
|
2022
Q2 | $1.31M | Buy |
25,082
+1,000
| +4% | +$51K | 0.15% | 61 |
|
|
2022
Q1 | $1.25M | Hold |
24,082
| – | – | 0.12% | 63 |
|
|
2021
Q4 | $1.42M | Buy |
24,082
+990
| +4% | +$49.1K | 0.13% | 61 |
|
|
2021
Q3 | $993K | Sell |
23,092
-240
| -1% | -$10.6K | 0.1% | 69 |
|
|
2021
Q2 | $914K | Buy |
23,332
+1,571
| +7% | +$61.1K | 0.09% | 72 |
|
|
2021
Q1 | $788K | Sell |
21,761
-132
| -0.6% | -$4.69K | 0.09% | 73 |
|
|
2020
Q4 | $806K | Sell |
21,893
-412
| -2% | -$15.1K | 0.09% | 76 |
|
|
2020
Q3 | $777K | Sell |
22,305
-87
| -0.4% | -$3.05K | 0.1% | 71 |
|
|
2020
Q2 | $695K | Buy |
22,392
+4
| +0% | +$136 | 0.1% | 72 |
|
|
2020
Q1 | $693K | Sell |
22,388
-376
| -2% | -$12.8K | 0.12% | 71 |
|
|
2019
Q4 | $846K | Buy |
22,764
+11,851
| +109% | +$422K | 0.12% | 69 |
|
|
2019
Q3 | $372K | Buy |
10,913
+198
| +2% | +$7.2K | 0.06% | 99 |
|
|
2019
Q2 | $440K | Sell |
10,715
-1,154
| -10% | -$45.8K | 0.07% | 89 |
|
|
2019
Q1 | $478K | Sell |
11,869
-770
| -6% | -$30.8K | 0.08% | 87 |
|
|
2018
Q4 | $523K | Sell |
12,639
-3,492
| -22% | -$145K | 0.11% | 77 |
|
|
2018
Q3 | $674K | Buy |
16,131
+1,039
| +7% | +$40K | 0.11% | 79 |
|
|
2018
Q2 | $519K | Sell |
15,092
-1,006
| -6% | -$34.4K | 0.1% | 85 |
|
|
2018
Q1 | $542K | Sell |
16,098
-3,526
| -18% | -$121K | 0.1% | 87 |
|
|
2017
Q4 | $674K | Sell |
19,624
-4,174
| -18% | -$142K | 0.13% | 78 |
|
|
2017
Q3 | $806K | Sell |
23,798
-343
| -1% | -$11K | 0.17% | 68 |
|
|
2017
Q2 | $769K | Hold |
24,141
| – | – | 0.17% | 70 |
|
|
2017
Q1 | $784K | Sell |
24,141
-126
| -0.5% | -$3.97K | 0.18% | 70 |
|
|
2016
Q4 | $748K | Buy |
24,267
+1,792
| +8% | +$54.7K | 0.19% | 71 |
|
|
2016
Q3 | $722K | Hold |
22,475
| – | – | 0.18% | 73 |
|
|
2016
Q2 | $751K | Sell |
22,475
-454
| -2% | -$14.5K | 0.2% | 69 |
|
|
2016
Q1 | $645K | Buy |
22,929
+633
| +3% | +$18.1K | 0.17% | 73 |
|
|
2015
Q4 | $683K | Sell |
22,296
-2,875
| -11% | -$90.4K | 0.18% | 76 |
|
|
2015
Q3 | $750K | Sell |
25,171
-843
| -3% | -$27K | 0.21% | 74 |
|
|
2015
Q2 | $828K | Sell |
26,014
-3,281
| -11% | -$107K | 0.21% | 75 |
|
|
2015
Q1 | $967K | Buy |
29,295
+10,495
| +56% | +$334K | 0.25% | 68 |
|
|
2014
Q4 | $556K | Buy |
18,800
+696
| +4% | +$20K | 0.17% | 77 |
|
|
2014
Q3 | $508K | Hold |
18,104
| – | – | 0.16% | 79 |
|
|
2014
Q2 | $510K | Buy |
18,104
+307
| +2% | +$8.75K | 0.15% | 83 |
|
|
2014
Q1 | $542K | Buy |
17,797
+603
| +4% | +$18K | 0.17% | 77 |
|
|
2013
Q4 | $500K | Buy |
17,194
+4,658
| +37% | +$136K | 0.16% | 81 |
|
|
2013
Q3 | $342K | Buy |
12,536
+11,166
| +815% | +$304K | 0.13% | 89 |
|
|
2013
Q2 | $36K | Buy |
+1,370
| New | +$37.9K | 0.02% | 133 |
|
Other funds holding PFE
VCM
VPM
Hemenway Trust Hemenway Trust's PFE Position: Q1 2026 in Review
Hemenway Trust Hemenway Trust held its Pfizer (PFE) position steady in Q1 2026 at 11,000 shares worth $309K. The position accounts for 0.02% of the portfolio, ranked #103.
Hemenway Trust Hemenway Trust first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.42M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Hemenway Trust Hemenway Trust held 11,000 shares of Pfizer worth $309K as of Q1 2026.
- Hemenway Trust Hemenway Trust left its Pfizer share count unchanged in Q1 2026.
- Pfizer made up 0.02% of Hemenway Trust Hemenway Trust's portfolio in Q1 2026, its #103 holding.
- Hemenway Trust Hemenway Trust first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Hemenway Trust Hemenway Trust's Pfizer position peaked at $1.42M in Q4 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Hemenway Trust Hemenway Trust's 13F filing for Q1 2026, filed 7 May 2026.